Baalasubramanian Sivasankar, Harris Claire L, Donev Rossen M, Mizuno Masashi, Omidvar Nader, Song Wen-Chao, Morgan B Paul
Complement Biology Group, Department of Medical Biochemistry and Immunology, University of Wales College of Medicine, Cardiff, United Kingdom.
J Immunol. 2004 Sep 15;173(6):3684-92. doi: 10.4049/jimmunol.173.6.3684.
Gene-deleted mice have provided a potent tool in efforts to understand the roles of complement and complement-regulating proteins in vivo. In particular, mice deficient in the membrane regulators complement receptor 1-related gene/protein y, decay-accelerating factor, or CD59 have demonstrated homeostatic relevance and backcrossing between the strains has revealed cooperativity in regulation. In mouse, genes encoding decay-accelerating factor and CD59 have been duplicated and show differential expression in tissues, complicating interpretation and extrapolation of findings to man. The first described form of CD59, CD59a, is broadly distributed and deletion of the cd59a gene causes a mild hemolytic phenotype with increased susceptibility in complement-mediated disease models. The distribution of the second form, CD59b, was originally described as testis specific, but later by some as widespread. Deletion of the cd59b gene caused a severe hemolytic and thrombotic phenotype. To apply data from these mouse models to man it is essential to know the relative distribution and functional roles of these two forms of CD59. We have generated new specific reagents and used them in sensitive quantitative analyses to comprehensively characterize expression of mRNA and protein and functional roles of CD59a and CD59b in wild-type (wt) and CD59a-negative mice. cd59b mRNA was detected only in testis and, at very low levels, in bone marrow. CD59b protein was present on mature spermatozoa and precursors and, in trace amounts, erythrocytes. Erythrocyte CD59b did not inhibit complement lysis except when CD59a was absent or blocked. These data confirm that CD59a is the primary regulator of complement membrane attack in mouse.
基因敲除小鼠为了解补体及补体调节蛋白在体内的作用提供了一个有力工具。特别是,缺乏膜调节因子补体受体1相关基因/蛋白Y、衰变加速因子或CD59的小鼠已证明了其体内平衡相关性,并且品系间的回交揭示了调节中的协同作用。在小鼠中,编码衰变加速因子和CD59的基因已被复制,并在组织中表现出差异表达,这使得将研究结果解释和外推至人类变得复杂。最早描述的CD59形式,即CD59a,分布广泛,cd59a基因的缺失会导致轻度溶血表型,在补体介导的疾病模型中易感性增加。第二种形式CD59b的分布最初被描述为睾丸特异性,但后来有人认为其分布广泛。cd59b基因的缺失导致严重的溶血和血栓形成表型。为了将这些小鼠模型的数据应用于人类,了解这两种形式的CD59的相对分布和功能作用至关重要。我们制备了新的特异性试剂,并将其用于灵敏的定量分析,以全面表征野生型(wt)和CD59a阴性小鼠中mRNA和蛋白质的表达以及CD59a和CD59b的功能作用。仅在睾丸中检测到cd59b mRNA,在骨髓中检测到的水平非常低。CD59b蛋白存在于成熟精子及其前体上,在红细胞中含量微量。红细胞CD59b除了在CD59a缺失或被阻断时外,不抑制补体溶解。这些数据证实CD59a是小鼠补体膜攻击的主要调节因子。